MedPath
NMPA Approval

DaShanZha Granules

国药准字Z32020282

January 7, 2021

国药准字Z32020282

Drug Information

大山楂颗粒

颗粒剂

每瓶装150g

中药

January 7, 2021

Company Information

Applicant Company

扬州市邗江区新甘泉西路69号

Manufacturing Company

扬州市李典镇新坝吴桥

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

大山楂颗粒 - NMPA 批准文号 | MedPath